BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15533308)

  • 21. Phosphatidylserine-binding protein lactadherin inhibits protein translocation across the ER membrane.
    Yamamoto H; Kida Y; Sakaguchi M
    Biochem Biophys Res Commun; 2013 May; 434(3):620-6. PubMed ID: 23583395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the factor VIIIa-factor IXa enzyme complex of blood coagulation by membranes containing phosphatidyl-L-serine.
    Gilbert GE; Arena AA
    J Biol Chem; 1996 May; 271(19):11120-5. PubMed ID: 8626656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid structure and not membrane structure is the major determinant in the regulation of protein kinase C by phosphatidylserine.
    Johnson JE; Zimmerman ML; Daleke DL; Newton AC
    Biochemistry; 1998 Sep; 37(35):12020-5. PubMed ID: 9724512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphatidylserine Lateral Organization Influences the Interaction of Influenza Virus Matrix Protein 1 with Lipid Membranes.
    Bobone S; Hilsch M; Storm J; Dunsing V; Herrmann A; Chiantia S
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28356535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insights into the complex association of bovine factor Va with acidic-lipid-containing synthetic membranes.
    Cutsforth GA; Koppaka V; Krishnaswamy S; Wu JR; Mann KG; Lentz BR
    Biophys J; 1996 Jun; 70(6):2938-49. PubMed ID: 8744332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy induces enhanced procoagulant activity through phosphatidylserine exposure in acute lymphoblastic leukemia.
    Dong X; Shi J; Zhou J; Chen X; Jin Y; Zhang X; Li X; Dai H; Wang J
    Thromb Res; 2013 Nov; 132(5):614-20. PubMed ID: 24074703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of the phosphatidylserine binding properties of the lipid biosensor, Lactadherin C2 (LactC2), in different membrane environments.
    Del Vecchio K; Stahelin RV
    J Bioenerg Biomembr; 2018 Feb; 50(1):1-10. PubMed ID: 29426977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Membrane binding kinetics of factor VIII indicate a complex binding process.
    Bardelle C; Furie B; Furie BC; Gilbert GE
    J Biol Chem; 1993 Apr; 268(12):8815-24. PubMed ID: 8473326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of the formation and activity of factor V-phospholipid complexes. I. Influence of phospholipid structure.
    Kandall CL; Shohet SB; Akinbami TK; Colman RW
    Thromb Diath Haemorrh; 1975 Sep; 34(1):256-70. PubMed ID: 1237944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activity.
    Gilbert GE; Novakovic VA; Kaufman RJ; Miao H; Pipe SW
    Blood; 2012 Aug; 120(9):1923-32. PubMed ID: 22613792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phospholipid binding of annexin V: effects of calcium and membrane phosphatidylserine content.
    Tait JF; Gibson D
    Arch Biochem Biophys; 1992 Oct; 298(1):187-91. PubMed ID: 1388011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strength of Ca(2+) binding to retinal lipid membranes: consequences for lipid organization.
    Huster D; Arnold K; Gawrisch K
    Biophys J; 2000 Jun; 78(6):3011-8. PubMed ID: 10827979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of blood coagulation factor VIII and its light chain to phosphatidylserine/phosphatidylcholine bilayers as measured by ellipsometry.
    Spaargaren J; Giesen PL; Janssen MP; Voorberg J; Willems GM; van Mourik JA
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):539-45. PubMed ID: 7654192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lactadherin functions as a probe for phosphatidylserine exposure and as an anticoagulant in the study of stored platelets.
    Hou J; Fu Y; Zhou J; Li W; Xie R; Cao F; Gilbert GE; Shi J
    Vox Sang; 2011 Feb; 100(2):187-95. PubMed ID: 20738837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lactadherin detects early phosphatidylserine exposure on immortalized leukemia cells undergoing programmed cell death.
    Shi J; Shi Y; Waehrens LN; Rasmussen JT; Heegaard CW; Gilbert GE
    Cytometry A; 2006 Dec; 69(12):1193-201. PubMed ID: 17123296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of microsphere-supported phospholipid membranes for analysis of protein-lipid interactions.
    Gilbert GE
    Curr Protoc Cytom; 2005 Nov; Chapter 13():Unit13.3. PubMed ID: 18770819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bovine lactadherin as a calcium-independent imaging agent of phosphatidylserine expressed on the surface of apoptotic HeLa cells.
    Waehrens LN; Heegaard CW; Gilbert GE; Rasmussen JT
    J Histochem Cytochem; 2009 Oct; 57(10):907-14. PubMed ID: 19546474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lactadherin inhibits secretory phospholipase A2 activity on pre-apoptotic leukemia cells.
    Nyegaard S; Novakovic VA; Rasmussen JT; Gilbert GE
    PLoS One; 2013; 8(10):e77143. PubMed ID: 24194865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Membrane curvature and PS localize coagulation proteins to filopodia and retraction fibers of endothelial cells.
    Carman CV; Nikova DN; Sakurai Y; Shi J; Novakovic VA; Rasmussen JT; Lam WA; Gilbert GE
    Blood Adv; 2023 Jan; 7(1):60-72. PubMed ID: 35849711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lactadherin binds to elastin--a starting point for medin amyloid formation?
    Larsson A; Peng S; Persson H; Rosenbloom J; Abrams WR; Wassberg E; Thelin S; Sletten K; Gerwins P; Westermark P
    Amyloid; 2006 Jun; 13(2):78-85. PubMed ID: 16911961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.